{
  "resourceType": "CodeSystem",
  "status": "draft",
  "content": "complete",
  "name": "HIV_Configuration",
  "id": "HIV.Configuration",
  "title": "HIV.Configuration CodeSystem",
  "description": "CodeSystem for HIV.Configuration  Data Elements",
  "url": "http://worldhealthorganization.github.io/smart-hiv/CodeSystem/HIV.Configuration",
  "concept": [
    {
      "code": "DE1",
      "display": "Population prevalence of TB",
      "definition": "The tuberculosis prevalence in the general population in number of cases per 100 000 persons or greater."
    },
    {
      "code": "DE2",
      "display": "Population prevalence of soil-transmitted helminth infection",
      "definition": "The percentage of individuals in the general population infected with at least one species of soil-transmitted helminths"
    },
    {
      "code": "DE3",
      "display": "Population incidence of HIV in the absence of PrEP",
      "definition": "HIV incidence number of cases per 100 personâ€“years in the absence of PrEP"
    },
    {
      "code": "DE4",
      "display": "Population prevalence of HIV",
      "definition": "The proportion of the population that are HIV-positive"
    },
    {
      "code": "DE5",
      "display": "Prevalence of pretreatment NNRTI drug resistance",
      "definition": "Prevalence of pretreatment HIV drug resistance to NNRTIs among people initiating first-line ART"
    },
    {
      "code": "DE6",
      "display": "Malaria-endemic setting",
      "definition": "Whether the setting is a malaria-endemic setting"
    },
    {
      "code": "DE7",
      "display": "Population prevalence of syphilis",
      "definition": "The proportion of the population with syphilis"
    },
    {
      "code": "DE8",
      "display": "Population prevalence of hepatitis B",
      "definition": "The proportion of hepatitis B surface antigen (HBsAg) seroprevalence in the general population"
    },
    {
      "code": "DE9",
      "display": "Population prevalence of hepatitis C",
      "definition": "The proportion of hepatitis C virus (HCV) antibody seroprevalence in the general population"
    },
    {
      "code": "DE10",
      "display": "Prevalence of HIV in the catchment area",
      "definition": "The proportion of the population from the health facility's catchment area that are HIV-positive (estimated)"
    },
    {
      "code": "DE11",
      "display": "Ultrasound available at the health facility",
      "definition": "Whether an ultrasound machine is available and functional in the facility and a trained health worker is available to use it"
    },
    {
      "code": "DE12",
      "display": "HIV burden of the setting",
      "definition": "HIV burden of the setting (high or low) based on the national HIV prevalence or where the HIV prevalence and/or incidence in a geographical setting is higher than national prevalence and, therefore, needs priority in the HIV response"
    },
    {
      "code": "DE13",
      "display": "High HIV burden setting",
      "definition": "Settings with >5% national HIV prevalence and subpopulations and geographic settings where HIV prevalence and/or incidence is higher than nationally."
    },
    {
      "code": "DE14",
      "display": "Low HIV burden setting",
      "definition": "Settings with <5% HIV national prevalence but where certain populations (primarily key populations and their partners) and geographic settings may have higher HIV prevalence and/or incidence than nationally and, therefore, need priority in the HIV response"
    },
    {
      "code": "DE15",
      "display": "HPV DNA testing operational at the health facility",
      "definition": "Is HPV DNA testing operational at the health facility for cervical cancer screening?"
    },
    {
      "code": "DE16",
      "display": "Routine viral load testing is available",
      "definition": "Routine viral load testing is available in the facility"
    },
    {
      "code": "DE17",
      "display": "Health facility ID",
      "definition": "Unique ID of the health facility that recorded the client. This ID could represent a universal health facility ID, if used in the country. Alternatively this ID can also be generated by the national surveillance system and assigned to reporting facility."
    },
    {
      "code": "DE18",
      "display": "TB treating facility ID",
      "definition": "The facility where the client is receiving tuberculosis (TB) treatment"
    },
    {
      "code": "DE19",
      "display": "Other priority populations",
      "definition": "Other populations of priority of HIV prevention and care in local context (provided during adaptation)"
    },
    {
      "code": "DE20",
      "display": "Reporting period end date",
      "definition": "End date of the reporting period"
    },
    {
      "code": "DE21",
      "display": "Reporting period start date",
      "definition": "Start date of the reporting period"
    },
    {
      "code": "DE22",
      "display": "Reporting date",
      "definition": "Reporting date, for surveys performed on a specific date"
    }
  ],
  "experimental": false,
  "caseSensitive": false,
  "count": 22
}
